These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12069384)

  • 1. Design of anti-bacterial drug and anti-mycobacterial drug for drug delivery system.
    Yanagihara K
    Curr Pharm Des; 2002; 8(6):475-82. PubMed ID: 12069384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection.
    Mehta RT
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1893-902. PubMed ID: 8843300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages.
    Majumdar S; Flasher D; Friend DS; Nassos P; Yajko D; Hadley WK; Düzgüneş N
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2808-15. PubMed ID: 1482150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-encapsulated antibiotics.
    Salem II; Flasher DL; Düzgüneş N
    Methods Enzymol; 2005; 391():261-91. PubMed ID: 15721386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New antimycobacterial agents.
    Cynamon MH; Klemens SP
    Clin Chest Med; 1989 Sep; 10(3):355-64. PubMed ID: 2505963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection.
    Oh YK; Nix DE; Straubinger RM
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2104-11. PubMed ID: 8540724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice.
    Düzgüneş N; Perumal VK; Kesavalu L; Goldstein JA; Debs RJ; Gangadharam PR
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1404-11. PubMed ID: 3196002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of liposome-encapsulated kanamycin against Mycobacterium intracellulare infection induced in mice.
    Tomioka H; Saito H; Sato K; Yoneyama T
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):575-9. PubMed ID: 1892297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages.
    Onyeji CO; Nightingale CH; Nicolau DP; Quintiliani R
    Antimicrob Agents Chemother; 1994 Mar; 38(3):523-7. PubMed ID: 8203849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides.
    Bermudez LE; Yau-Young AO; Lin JP; Cogger J; Young LS
    J Infect Dis; 1990 Jun; 161(6):1262-8. PubMed ID: 2345306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice.
    Gangadharam PR; Ashtekar DA; Ghori N; Goldstein JA; Debs RJ; Düzgünes N
    J Antimicrob Chemother; 1991 Sep; 28(3):425-35. PubMed ID: 1960123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease.
    Shirley M
    Drugs; 2019 Apr; 79(5):555-562. PubMed ID: 30877642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium avium complex infection. Pharmacokinetic and pharmacodynamic considerations that may improve clinical outcomes.
    Peloquin CA
    Clin Pharmacokinet; 1997 Feb; 32(2):132-44. PubMed ID: 9068928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies.
    Schiffelers R; Storm G; Bakker-Woudenberg I
    J Antimicrob Chemother; 2001 Sep; 48(3):333-44. PubMed ID: 11532996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Mycobacterium avium-intracellulare complex infection in beige mice with free and liposome-encapsulated streptomycin: role of liposome type and duration of treatment.
    Düzgüneş N; Ashtekar DR; Flasher DL; Ghori N; Debs RJ; Friend DS; Gangadharam PR
    J Infect Dis; 1991 Jul; 164(1):143-51. PubMed ID: 2056201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice.
    Deol P; Khuller GK; Joshi K
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1211-4. PubMed ID: 9174172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.